President & Immunovant CEO
Mon, Jan 12, 2026
Jan 12
200,000 shares @ $21.92
Decreased holdings by -10.80%
23rd largest trade (out of 285)
Large Trade
Trade made by an officer
10b5-1 scheduled trade
34% win rate · -5.8% median edge vs SPY (80 trades, 90-day)
Price 52% above 200-day moving average